Epstein-Barr Virus and PD-L1 in Esophageal and Esophagogastric Junction Cancer: Differences According to Location and Histological Type

J Gastrointest Surg. 2022 Nov;26(11):2358-2364. doi: 10.1007/s11605-022-05377-y. Epub 2022 Jun 6.
No abstract available

Keywords: Epstein-Barr virus (EBV)-associated tumors; Esophagogastric junction adenocarcinoma; Gastric adenocarcinoma; Molecular classification; Programmed death-ligand 1 (PD-L1); Squamous cell carcinoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • B7-H1 Antigen
  • Biomarkers, Tumor
  • Epstein-Barr Virus Infections* / complications
  • Epstein-Barr Virus Infections* / pathology
  • Esophagogastric Junction / pathology
  • Herpesvirus 4, Human
  • Humans
  • Neoplasms*
  • Stomach Neoplasms* / pathology

Substances

  • B7-H1 Antigen
  • Biomarkers, Tumor